Srikrishna T., Y. Prapurnachandra, P. Venugopalaih, Syed Shahistha*, V. Umadevi, P. Ramya and C. Jhansi Rani


Fungal keratitis or fungal corneal ulcer is potentially binding infection of cornea, is considered one of the major cause of ocular morbidity, particularly in developing countries. Infectious keratitis is frequently caused by it, particularly in tropical and subtropical nations. Mycotic or fungal keratitis, as well as keratomycosis, are fungus-related infections of the cornea that manifest as purulent, typically ulcerative, lesions. Because of its propensity to mimic other forms of stromal inflammation and because its care is limited by the availability of potent antifungal drugs and their capacity to enter corneal tissue, this type of corneal infection presents a challenge to the ophthalmologist. Fungal keratitis is renowned for being hard to diagnose and treat. Reports of mycotic keratitis have been received from all over the world, but especially from tropical regions where it may be responsible for over half of all cases of microbial keratitis and ocular mycoses. There are two primary kinds that are known to exist: keratitis caused by yeast-like and related fungus (specifically Candida) and those caused by filamentous fungi (mostly Fusarium and Aspergillus), which are widespread in tropical and subtropical zones. Fungal infections in the cornea can have irreversible aftereffects if treatment is postponed. Treatment results for fungal keratitis are frequently worse than those for bacterial keratitis. The main causes of the poor result are inadequate antifungal medications and delayed diagnosis. Significant progress in treatment has been made in the last few years. The pathophysiology, clinical characteristics, therapy, and epidemiology of fungal keratitis are reviewed in this topic.

Keywords: Infectious keratitis, fungal keratitis, Aspergillus, antifungal medications and keratoplasty.

[Full Text Article]   [Download Certificate]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    APRIL 2024 Issue has been successfully launched on 1 APRIL 2024.

  • EJBPS New Impact Factor

    EJBPS Impact Factor has been Increased to 7.482 for Year 2024.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction